Common Stock SEC Reporting - Current
Verified Company Profile 10/03/2017
Contact Info
  • 1275 W. Washington Street
  • Suite 104
  • Tempe, AZ 85281

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000887151
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 2 a/o Dec 16, 2014
Company Officers/Contacts
John M Holliman CEO
Les Taeger CFO
Barbara Dunford Executive Assistant
Company Directors
John M Holliman Chairman
Frederic J Feldman
Elwood D Howse
Matthew E. Lipman Audit Committee Member
Michael M. Toporek Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Eide Bailly LLP
4310 17th Avenue S.
Fargo, ND, 58103
United States
Securities Counsel
Quarles & Brady LLP
1700 K St NW
Washington, D.C., DC, 20006
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=OrthoLogic Corp. until 5-2010
CAPS Security Details
Share Structure
Market Value1 $2,991,198 a/o Oct 20, 2017
Authorized Shares 150,000,000 a/o Oct 19, 2017
Outstanding Shares 54,385,411 a/o Oct 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC 40,225,879 a/o Oct 19, 2017
Float Not Available
Par Value 0.0005
Transfer Agent(s) Verified by Transfer Agent
Shareholders of Record 748 a/o Feb 28, 2017
Short Selling Data
Short Interest 0 (-100%)
Jan 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security